Neoadjuvant tislelizumab combined with APF for patients with locally advanced head and neck squamous cell carcinoma: A prospective single-arm clinical trial

被引：0
|
作者：
Yan, Jing
Wang, Kong-cheng
Yang, Mi
Gu, Ya-Jun
Huang, Bin
Zhu, Yahui
Sha, Hui-zi
Zhu, Jing
Zhu, Chan
Chen, Dong-sheng
Qian, Xiao-Yun
Shen, Xiao-hui
Chen, Hong
机构：
[1] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Ctr Comprehens Canc, Nanjing, Peoples R China
[2] Nanjing Univ, Clin Canc Inst, Nanjing, Peoples R China
[3] Nanjing Med Univ, Nanjing Drum Tower Hosp, Clin Coll, Nanjing, Peoples R China
[4] Jiangsu Simcere Diagnost Co Ltd, Nanjing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6080
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Neoadjuvant chemotherapy combined with camrelizumab for locally advanced head and neck squamous cell carcinoma: A phase II trial
    Yang, K.
    Zhang, X.
    Zhang, Z.
    Wu, B.
    Peng, G.
    Huang, J.
    Ding, Q.
    Xiao, G.
    Ma, H.
    Yang, C.
    Xiong, X.
    Shi, L.
    Yang, J.
    Hong, X.
    Wei, J.
    Qin, Y.
    Zhong, Y.
    Zhou, Y.
    Zhao, X.
    Leng, Y.
    ANNALS OF ONCOLOGY, 2021, 32 : S1442 - S1443
  • [22] Neoadjuvant toripalimab combined with gemcitabine and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NeoTGP01): An open-label, single-arm, phase Ib clinical trial.
    Liu, Zhigang
    Huang, Xiaotao
    Liang, Jun
    Zhong, Guihua
    Liu, Ye
    Liang, Lizhong
    Hong, Haiyu
    Feng, Weineng
    Yang, Shuang
    Zhang, Yaqin
    Peng, Yingpeng
    Liu, Qiandan
    Zhou, Yuling
    Zhang, Zhaoyuan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [23] Tislelizumab combined with neoadjuvant chemoradiotherapy for resectable locally advanced oesophageal squamous cell carcinoma: A prospective, phase II clinical study
    Zhang, Y.
    Yuan, Y.
    Xu, Y.
    Tian, R.
    Liao, J.
    Zeng, X.
    Wang, Y.
    Liu, Y.
    Zhou, X.
    Peng, F.
    Zhou, L.
    Wang, H.
    Hou, W.
    Yu, M.
    Xiu, W.
    Huang, M.
    Zhang, X.
    Gong, Y.
    Lu, Y.
    Zou, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S865 - S865
  • [24] NEOADJUVANT TORIPALIMAB COMBINED WITH AXITINIB IN PATIENTS WITH LOCALLY ADVANCED CLEAR CELL RENAL CELL CARCINOMA: A SINGLE-ARM, PHASE II TRIAL
    Huang, Jiwei
    JOURNAL OF UROLOGY, 2024, 211 (05): : E712 - E713
  • [25] Neoadjuvant toripalimab combined with axitinib in patients with locally advanced clear cell renal cell carcinoma: a single-arm, phase II trial
    Huang, Jiwei
    Wang, Yueming
    Xu, Fan
    Wang, Zaoyu
    Wu, Guangyu
    Kong, Wen
    Cheoklong, Ng
    Tricard, Thibault
    Wu, Xiaorong
    Zhai, Wei
    Zhang, Wei
    Zhang, Jiyang
    Zhang, Ding
    Chen, Shuyin
    Lian, Yuqing
    Chen, Yonghui
    Zhang, Jin
    Huang, Yiran
    Xue, Wei
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (06)
  • [26] Neoadjuvant chemoimmunotherapy for the treatment of locally advanced laryngeal and hypopharyngeal squamous cell carcinoma: A single-arm phase 2 clinical trial.
    Chen, Yanfeng
    Yang, Ankui
    Mao, Yan-Ping
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [27] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
  • [28] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [29] Neoadjuvant tislelizumab combined with chemoradiotherapy for resectable locally advanced esophageal squamous cell carcinoma (ESCC): Single arm phase II study
    Jin, Peng
    Gao, Yong Sheng
    Fu, Zheng
    Yang, Wen Feng
    Meng, Xue
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [30] Multi-omics analysis of tislelizumab plus nab-paclitaxel and cisplatin as neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A prospective single-arm phase II trial
    Xie, Z.
    Zhang, W.
    Chen, X.
    Wang, X.
    Liu, S.
    Yi, J.
    An, C.
    Lu, H.
    Yao, J.
    Zhu, H.
    Xie, T.
    Tang, L.
    He, X.
    Shi, Y.
    Gui, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S641 - S641
12345